Addgene Expands Viral Vector Service with Packaged on Request
WATERTOWN, Mass.–(BUSINESS WIRE)–Addgene announces the expansion of its viral vector service with Packaged on Request.
Read More
Unum Group Declares Quarterly Dividend of $0.420 Per Share of its Common Stock
CHATTANOOGA, Tenn.–(BUSINESS WIRE)–Effective January 9, 2025, the Unum Group (NYSE: UNM) Board of Directors declared a quarterly dividend of $0.420 per share on its common stock to be paid February 14, 2025, to stockholders of record as of January 24, 2025. About Unum Group Unum Group (NYSE: UNM), a leading international provider of workplace benefits and services, has been helping workers and their families thrive for more than 175 years. Through its Unum and Colonial Life brands, the compan
Exact Sciences Announces Preliminary Fourth Quarter 2024 Results
MADISON, Wis.–(BUSINESS WIRE)–Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company expects to report revenue of $713 million for the fourth quarter ended December 31, 2024. “The Exact Sciences team delivered strong results to finish 2024, setting us up for sustained growth and profitability in the years to come,” said Kevin Conroy, chairman and CEO. “We look forward to expanding our impact as the platform supporting
Parse Biosciences將Evercode WT Mega套組的樣本復用能力提高了四倍
西雅圖–(BUSINESS WIRE)–(美國商業資訊)– 可得且可擴展的單細胞定序解決方案一流供應商Parse Biosciences今天宣布大幅擴展其Evercode™ WT Mega套組的功能。研究人員現能夠一次分析多達384個樣本和100萬個細胞，為高通量研究帶來了新的可能性。 雖然單細胞技術穩步發展，但其中許多在同時處理大量細胞和樣本時仍然受限。而這些功能正是研究人員進行高通量藥物篩選、基因篩選和時間序列實驗所需要的，這些實驗對可擴展性和精確性都有很高的要求。透過Evercode WT Mega套組的擴展功能，科學家可以在一次實驗中篩選384個樣本中的100萬個細胞，從而簡化工作流程並獲得新發現。 新功能在與Evercode™低投入量固定細胞套組相結合後進一步增強，為研究人員在每個樣本細胞數量有限的情況下工作提供了額外的優勢。此組合尤其有利於稀有或珍貴樣本類型，即使樣本投入量較低，也能對多種條件和重複樣本進行穩健測試。 Parse Biosciences共同創辦人暨技術長Charlie Roco表示：「我們很高興能為研究界提供這項功能。能夠同時分析如此大量的樣本和細胞，
Immunis Closes $25 Million Series A-1 Financing Round
IRVINE, Calif.–(BUSINESS WIRE)– #ClinicalTrials–Immunis, Inc., a clinical-stage biotech developing multi-active biologics for age and disease-related immune dysregulation, has closed a $25 million Series A-1 financing round to fund two Phase 2 clinical trials. Follow-on investments from all major existing investors, notably, Remiges Ventures, Continuum Health Ventures and BOLD Capital Partners were joined by new investments from LifeSpan Vision Ventures and JLS Fund among others, including a leading global in
Genital herpes is on the rise. Here’s what to know about this common infection
The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and 49 live with a genital herpes infection.
Ovation.io Launches Comprehensive Research Data Set of Whole Genome Sequences and Longitudinal Clinical Records for Patients Treated with GLP-1 agonists
PORTLAND, Maine–(BUSINESS WIRE)– #Bioinformatics–Ovation launches a GLP-1 dataset with WGS enabling biomaker discovery to advance precision medicine in metabolic diseases.
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found those insured through Medicare Advantage received less expensive cancer drugs compared to others on Traditional Medicare.
New contrast agent for ultrasound imaging tested to make medical diagnostics more affordable and safe
Skoltech researchers and their colleagues have synthesized and tested protein-polymer microbubbles for use in medical ultrasound imaging of internal organs. Administered intravenously, the microbubbles act as a contrast agent, enhancing the quality of the image.
Montecito Medical Named Key Influencer in Healthcare Real Estate
NASHVILLE, Tenn.–(BUSINESS WIRE)–Once again, Montecito Medical has been named as a “Key Influencer in Healthcare Real Estate.” The national recognition came from the editors of Real Estate Forum and GlobeSt. Partners, who publish an annual list of influencers in specific areas of real estate that include healthcare, retail, industrial and multifamily housing. This marks the seventh consecutive year that the publication has named Montecito or its leadership as Key Influencers in the medical re